Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Total Non-Current Liabilities (2020 - 2025)

Historic Total Non-Current Liabilities for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to -$2426.4 billion.

  • Universe Pharmaceuticals' Total Non-Current Liabilities fell 21351.49% to -$2426.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$2426.4 billion, marking a year-over-year decrease of 21351.49%. This contributed to the annual value of -$2426.4 billion for FY2025, which is 21351.49% down from last year.
  • Universe Pharmaceuticals' Total Non-Current Liabilities amounted to -$2426.4 billion in Q3 2025, which was down 21351.49% from $2137.5 billion recorded in Q3 2024.
  • Over the past 5 years, Universe Pharmaceuticals' Total Non-Current Liabilities peaked at $2137.5 billion during Q3 2024, and registered a low of -$2426.4 billion during Q3 2025.
  • In the last 5 years, Universe Pharmaceuticals' Total Non-Current Liabilities had a median value of $4.4 million in 2022 and averaged -$40.5 billion.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first tumbled by 17039660.09% in 2022, then skyrocketed by 1889094653.61% in 2024.
  • Over the past 5 years, Universe Pharmaceuticals' Total Non-Current Liabilities (Quarter) stood at $20.7 million in 2021, then tumbled by 170396.6% to -$35.3 billion in 2022, then soared by 100.03% to $11.3 million in 2023, then soared by 18890946.54% to $2137.5 billion in 2024, then tumbled by 213.51% to -$2426.4 billion in 2025.
  • Its Total Non-Current Liabilities was -$2426.4 billion in Q3 2025, compared to $2137.5 billion in Q3 2024 and $20.2 million in Q1 2024.